🏠 Home 🔍 Today's Scan 📰 Daily Report 📈 Hit Rate 📊 Base Rate ❓ Methodology 📚 Learn 🪙 Crypto Scanner 📋 All Tools ⏪ Investment Simulator 🧾 Tax Calculator🧮 Pension vs. Direct ⚡ Leverage ⚖️ Rebalancing 💹 DCA 📉 Averaging-Down B/E 💰 Dividend Calendar
🌅 Pre-Breakout Signal Scan Result
IBRX
Caution Breakout Imminent (Squeeze + Near Resistance) 🏷️ Healthcare sector 📅 Scanned: 2026.09.09 08:23
Pre-Breakout Score
86.0
⚠️ This risk flag is not a ranking — it reflects "chase / volatility risk if entering right now"
Watch

Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.

Caution

Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.

High Risk

Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.

Key Technical Indicators
RSI (14)
58
normal
ADX
21
weak trend
BB Squeeze
✓ Squeeze
bottom 0% band width
OBV Accum.
✓ 1.1x
inflow
Vol Ratio
1.1x
typical
5D Chg
+4.3%
short-term trend
1D Chg
+2.6%
vs. prior close
vs 20D High
+5.4%
near resistance
ATR%
4.8%
daily range
SPY RS 20D
+11.4%
strength vs. market
60-Day Price History
Close Volume Hover for details
Detected Signals (8)
Bollinger Band squeeze
OBV rising (inflow)
Trend strengthening (ADX 21↑·+DI lead)
Tight below resistance (-5.4% from high)
Strong close (small upper wick)
Short volume 55% (squeeze potential)
Good RS (+11.4%p vs SPY)
Multi-timeframe squeeze (daily + weekly contraction)
🌅 Technical Diagnostic Summary
IBRX is currently classified as 'Breakout Imminent (Squeeze + Near Resistance)' on technical indicators. RSI at 58 is neither overbought nor oversold — momentum is neutral. Bollinger Band width has contracted to the bottom 0% of its past year — an unusually extreme squeeze that often precedes a sharp volatility move. OBV is drifting mildly higher, suggesting low-intensity accumulation at most. ADX 21 suggests an early-stage trend, with buying pressure ahead of selling. 20-day relative strength vs. SPY of +11.4pp is a large lead over the market — a hallmark of early institutional buying. Price sits 5.4% below its 20-day high, approaching that resistance level. Flagged Caution on rising volatility or short-term overheating — approach with care.
📖 How to Read These Indicators

IBRX's RSI(14) currently reads 58. RSI compares the size of recent up moves to down moves to flag stretched conditions in either direction. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'normal' range. Treat this as one data point on IBRX, not a standalone signal. → Learn more

ADX currently reads 21. ADX tells you how convincing a trend is, leaving the up-or-down call to +DI/-DI (25+ is considered pronounced). Right now IBRX shows +DI sits above -DI, favoring the upside, putting it in the 'weak trend' range on ADX. As with any single metric, weigh this alongside IBRX's full indicator set. → Learn more

IBRX's Bollinger Band width is in the bottom 0% (narrow) of its past year, and the squeeze indicator is currently active. A Bollinger Band squeeze means price volatility has contracted well below its usual range. A squeeze is often followed by a volatility expansion in either direction. Cross-check this against IBRX's other indicators above before drawing a conclusion. → Learn more

IBRX's OBV is currently rising (1.1x), and the up/down volume ratio is 1.1x. OBV is a running tally that infers buying or selling pressure purely from volume direction. Treat this as one data point on IBRX, not a standalone signal. → Learn more

IBRX's recent volume is running at 1.1x its usual level. This ratio shows how many times normal volume the stock has been trading at lately — a reference point for whether order flow is concentrating around this stock. Treat this as one data point on IBRX, not a standalone signal. → Learn more

IBRX's change over the last 5 trading days is +4.3%, and over the last 1 trading day is +2.6%. These reflect only what has already happened over the past day and week, not what happens next.

IBRX's current price is 5.4% below its 20-day high. This measures, as of the 20-trading-day high, how far the current price sits from that level. On this measure it currently falls in the 'near resistance' category. As with any single metric, weigh this alongside IBRX's full indicator set. → Learn more

IBRX's ATR% currently reads 4.8%, a 'daily range' level. This is a running measure of how much the price typically moves in a single session. As with any single metric, weigh this alongside IBRX's full indicator set. → Learn more

IBRX's 20-trading-day relative strength versus SPY (S&P 500 ETF) is +11.4%. IBRX gained more (or lost less) than SPY over this stretch. Treat this as one data point on IBRX, not a standalone signal. → Learn more

📊 Measured Base Rates for IBRX's Active Signals · Full table

Stocks holding Bollinger Band Squeeze reached +15% 28.3% of the time, versus a 29.3% base rate — not a statistically significant difference (3949 cases). Cross-check this against IBRX's other indicators above before drawing a conclusion. → Bollinger Band Squeeze

Stocks holding OBV Accumulation reached +15% 26.5% of the time, versus a 29.3% base rate — not a statistically significant difference (6001 cases). Cross-check this against IBRX's other indicators above before drawing a conclusion. → OBV Accumulation

Stocks holding ADX Trend Strengthening reached +15% 29.5% of the time, versus a 29.3% base rate — not a statistically significant difference (6731 cases). Treat this as one data point on IBRX, not a standalone signal. → ADX Trend Strengthening

Stocks holding +DI Dominance reached +15% 27.0% of the time, versus a 29.3% base rate — not a statistically significant difference (8370 cases). Cross-check this against IBRX's other indicators above before drawing a conclusion. → +DI Dominance

No significant edge was measured for Weekly Squeeze: 25.4% versus a 29.3% base rate across 5281 cases. Cross-check this against IBRX's other indicators above before drawing a conclusion. → Weekly Squeeze

Measured (n=3350), the hit-rate for Relative Strength +8pp (20D) (34.6%) was not statistically distinguishable from the base rate (29.3%). As with any single metric, weigh this alongside IBRX's full indicator set. → Relative Strength +8pp (20D)

Among stocks holding Avg Daily Range 4%+, 59.5% reached +15% within 20 trading days — significantly above the full-universe base rate of 29.3% (2502 cases measured). This reading is specific to IBRX on this scan date and can change quickly. → Avg Daily Range 4%+

No significant edge was measured for Off-Exchange Short 50%+: 35.4% versus a 29.3% base rate across 3067 cases. As with any single metric, weigh this alongside IBRX's full indicator set. → Off-Exchange Short 50%+

Stocks holding Off-Exchange Short 40%+ reached +15% 36.2% of the time, versus a 29.3% base rate — not a statistically significant difference (4103 cases). As with any single metric, weigh this alongside IBRX's full indicator set. → Off-Exchange Short 40%+

Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (IBRX diagnostic as of 2026.09.09 08:23).

⚠️ This is a monitoring candidate only, not investment advice. The indicators, score, and diagnosis on this page are the result of technical screening and do not guarantee any return. Price can move up, sideways, or down from here, and any investment loss is the investor's own responsibility. Read the full disclaimer